Terms: = Brain cancer AND CIITA, P33076, 4261, ENSG00000179583, MHC2TA, C2TA
10 results:
1. Tim-3 Relieves Experimental Autoimmune Encephalomyelitis by Suppressing MHC-II.
Tang L; Li G; Zheng Y; Hou C; Gao Y; Hao Y; Gao Z; Mo R; Li Y; Shen B; Wang R; Wang Z; Han G
Front Immunol; 2021; 12():770402. PubMed ID: 35095844
[TBL] [Abstract] [Full Text] [Related]
2. ciita-Transduced Glioblastoma Cells Uncover a Rich Repertoire of Clinically Relevant Tumor-Associated HLA-II Antigens.
Forlani G; Michaux J; Pak H; Huber F; Marie Joseph EL; Ramia E; Stevenson BJ; Linnebacher M; Accolla RS; Bassani-Sternberg M
Mol Cell Proteomics; 2021; 20():100032. PubMed ID: 33592498
[TBL] [Abstract] [Full Text] [Related]
3. RACK7 recognizes H3.3G34R mutation to suppress expression of MHC class II complex components and their delivery pathway in pediatric glioblastoma.
Jiao F; Li Z; He C; Xu W; Yang G; Liu T; Shen H; Cai J; Anastas JN; Mao Y; Yu Y; Lan F; Shi YG; Jones C; Xu Y; Baker SJ; Shi Y; Guo R
Sci Adv; 2020 Jul; 6(29):eaba2113. PubMed ID: 32832624
[TBL] [Abstract] [Full Text] [Related]
4. Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study.
Bromberg JEC; Issa S; Bakunina K; Minnema MC; Seute T; Durian M; Cull G; Schouten HC; Stevens WBC; Zijlstra JM; Baars JW; Nijland M; Mason KD; Beeker A; van den Bent MJ; Beijert M; Gonzales M; de Jong D; Doorduijn JK
Lancet Oncol; 2019 Feb; 20(2):216-228. PubMed ID: 30630772
[TBL] [Abstract] [Full Text] [Related]
5. Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases.
Shah N; Mohammad AS; Saralkar P; Sprowls SA; Vickers SD; John D; Tallman RM; Lucke-Wold BP; Jarrell KE; Pinti M; Nolan RL; Lockman PR
Pharmacol Res; 2018 Jun; 132():47-68. PubMed ID: 29604436
[TBL] [Abstract] [Full Text] [Related]
6. The role of surgery in clinical management of patients with metastatic papillary renal cell carcinoma.
Steiner T; Kirchner H; Siebels M; Doehn C; Heynemann H; Varga Z; Rohde D; Schubert J; Jocham D; Stief C; Fornara P; Hofmann R; Loening S; Roigas J
J Cancer Res Clin Oncol; 2010 Jun; 136(6):905-10. PubMed ID: 20012752
[TBL] [Abstract] [Full Text] [Related]
7. Glucocorticoids enhance interleukin-4 production to neo-antigen (hyaluronidase) in children immunocompromised with cytostatic drugs.
Edelbauer M; Gerstmayr M; Loibichler C; Jost E; Huemer M; Urbanek R; Szépfalusi Z
Pediatr Allergy Immunol; 2002 Oct; 13(5):375-80. PubMed ID: 12431198
[TBL] [Abstract] [Full Text] [Related]
8. Malignant glioma cells use MHC class II transactivator (ciita) promoters III and IV to direct IFN-gamma-inducible ciita expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activation.
Soos JM; Krieger JI; Stüve O; King CL; Patarroyo JC; Aldape K; Wosik K; Slavin AJ; Nelson PA; Antel JP; Zamvil SS
Glia; 2001 Dec; 36(3):391-405. PubMed ID: 11746775
[TBL] [Abstract] [Full Text] [Related]
9. Tumor gene therapy made easy: allogeneic major histocompatibility complex in the C6 rat glioma model.
Beutler AS; Banck MS; Wedekind D; Hedrich HJ
Hum Gene Ther; 1999 Jan; 10(1):95-101. PubMed ID: 10022534
[TBL] [Abstract] [Full Text] [Related]
10. Kinase inhibitors abrogate IFN-gamma-induced class II transactivator and class II MHC gene expression in astroglioma cell lines.
Van Wagoner NJ; O'Keefe GM; Benveniste EN
J Neuroimmunol; 1998 May; 85(2):174-85. PubMed ID: 9630166
[TBL] [Abstract] [Full Text] [Related]
